Inhibitor kappa B-alpha (IκB-α) promoter polymorphisms in UK and Dutch sarcoidosis

This publication has 30 references indexed in Scilit:

• Immunopharmacological Potential of Selective Phosphodiesterase Inhibition. II. Evidence for the Involvement of an Inhibitory-κB/Nuclear Factor-κB-Sensitive Pathway in Alveolar Epithelial Cells
  The Journal of Pharmacology and Experimental Therapeutics, 2002
• Polymorphisms in the IκB-α promoter region and risk of diseases involving inflammation and fibrosis
  Genes & Immunity, 2001
• Diffuse lung disease: product of genetic susceptibility and environmental encounters
  Thorax, 1997
• Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)
  Tissue Antigens, 1995
• Zirconium granuloma resulting from an aluminum zirconium complex: A previously unrecognized agent in the development of hypersensitivity granulomas
  Journal of the American Academy of Dermatology, 1993
• Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis.
  Journal of Clinical Investigation, 1985
• Sarcoidosis in Causians, Blacks and Asians in London
  Respiratory Medicine, 1985
• Redistribution of T Lymphocytes in the Lymph Nodes of Patients with Sarcoidosis
  New England Journal of Medicine, 1982
• Pulmonary Sarcoidosis
  New England Journal of Medicine, 1981
• A TRANSMISSIBLE AGENT FROM SARCOID TISSUE
  The Lancet, 1969